Surmodics, Inc. - Common Stock (SRDX)

Competitors to Surmodics, Inc. - Common Stock (SRDX)

Abbott Laboratories 

Abbott competes with Surmodics primarily in in-vitro diagnostics and cardiovascular devices, where both companies focus on innovative technologies to improve patient outcomes. However, Abbott has greater financial resources, a wider portfolio of established products, and stronger brand recognition in the global market. They leverage their extensive R&D capabilities to enhance their product offerings, thereby maintaining a competitive edge over Surmodics, which is smaller and focuses on niche areas of coating technologies.

BD (Becton, Dickinson and Company) 

BD is a leading global medical technology company that competes with Surmodics across various segments, including injectable drug delivery systems and vascular access devices. BD's robust portfolio, combined with their strong distribution networks, allows them to reach a larger customer base, enhancing their competitiveness. While Surmodics has expertise in surface modifications and coatings, BD's overall scale, investments in technology, and established reputation as a market leader give them a significant competitive advantage.

iRhythm Technologies 

iRhythm Technologies competes with Surmodics in the cardiac monitoring space, focusing on digital health solutions and wearable technology for heart health. While Surmodics focuses on coatings and delivery systems, iRhythm has innovated in the realm of data analytics and patient-centered monitoring equipment. Although iRhythm is more specialized in cardiac solutions, their advanced technology and emphasis on data integration provide them a competitive edge in the growing telehealth market compared to Surmodics’ more traditional medical device focus.

Medtronic 

Medtronic is a global leader in medical technology and competes with Surmodics primarily in the area of drug delivery and vascular interventions. While Surmodics specializes in coatings and surface modifications for medical devices, Medtronic offers a broader range of advanced medical devices, including drug-eluting stents and insulin pumps. Medtronic's extensive experience, large-scale manufacturing, and established market presence give it a competitive advantage in terms of resources and market reach, allowing it to innovate and bring products to market more effectively than Surmodics.

Thermo Fisher Scientific 

Thermo Fisher Scientific competes with Surmodics primarily in the life sciences and diagnostics sectors. While Surmodics focuses on innovative surface technologies for medical devices, Thermo Fisher has a broad product portfolio that includes laboratory equipment, diagnostic solutions, and biopharma services. Their extensive research capabilities, large investment in new technologies, and diverse market applications offer them a competitive advantage over Surmodics, particularly in terms of scale and breadth of offerings.